PTJ
RXII

Paul Tudor Jones’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Paul Tudor Jones’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-11,400
Closed -$19K – 1932
2015
Q2 		$19K Buy
+11,400
New +$19K ﹤0.01% 1455
2014
Q2 		– Sell
-41,600
Closed -$104K – 1493
2014
Q1 		$104K Buy
+41,600
New +$104K ﹤0.01% 1122

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 28.54% 1-Year Est. Return

Paul Tudor Jones's RXII Position: Q3 2015 in Review

Paul Tudor Jones sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 11,400 shares — an estimated $19K sold.

Paul Tudor Jones first reported a position in RXII in Q1 2014 and held it in 2 quarters. The position peaked at $104K in Q1 2014. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

  • Paul Tudor Jones reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
  • Paul Tudor Jones sold 11,400 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $19K.
  • Paul Tudor Jones first reported a position in GALENA BIOPHARMA INC COM in Q1 2014 and held it in 2 quarters.
  • Paul Tudor Jones's GALENA BIOPHARMA INC COM position peaked at $104K in Q1 2014.
  • 78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Tudor Investment Corp's 13F filing for Q3 2015, filed 16 Nov 2015.